We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024 - UK" by Global Health & Pharma Magazine (GHP).
This prestigious recognition highlights our commitment to delivering innovative genomic data analysis solutions that drive Precision Medicine at scale. Our scalable, automated and integrated CE-marked products are designed to help reduce the burden on healthcare systems worldwide.
This award is a testament to the hard work and dedication of our team in advancing the field of genomic data analysis and Precision Medicine.
We extend our gratitude to GHP for this honor and to our customers, partners and patient advocates for their ongoing support. We look forward to continuing our mission to transform healthcare through the power of genomic data.
Alistair Johnson, Chief Commercial Officer at Congenica, said: “We are delighted to have been selected for this award! With a commitment to global quality standards, our fully automated, integrated, and scalable end-to-end solution is helping to drive Precision Medicine and enable healthcare providers to deliver the highest quality care to their patients.”
News
Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP
6/19/2024
|
0 min read
Related articles
Congenica showcased in Genomics Spotlight 2024 Report
We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT).
Congenica secures new two-year contract with Hong Kong Genome Project
Congenica announces a two-year extension to their contract with the Hong Kong Genome Project (HKGP).
Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials
Congenica and myTomorrows have partnered to expedite access to precision oncology for cancer patients worldwide.